Tetratherix says the US Food and Drug Administration has accepted the core of its application to sell Tegenix, its bone ...
The board said talks with prospective robotics and defence partners have convinced it that the sensor business is worth more ...
CSL has agreed to pay Alentis Therapeutics US$355 million upfront in an exclusive deal to jointly develop and promote ...
Average pay for chief executives of Australia's largest listed health care and biotechnology companies rose for a second consecutive year in 2026, while average pay at the smallest companies fell, ...
Citing the Australian Institute of Health and Welfare, BCAL says 48 per cent of women aged 50 to 74 skip routine breast screening.
Syntara has announced it will enlarge its clinical trial of a topical scar treatment. It is adding 10 participants and a new ...
Dr Chris Bremer has taken charge of Neurizon Therapeutics as the Melbourne company counts down to a critical trial result.
Paradigm Biopharmaceuticals has entered voluntary administration. The Melbourne drug developer made the move after an interim ...
The United States Food and Drug Administration has granted Telix Pharmaceuticals Fast Track designation for its BiPASS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results